Announcements Trials
Browse Landscape

Phase

Phase NA 53Phase 1 51Phase 2 28Phase 1/2 22Phase EARLY_PHASE1 17Phase 3 7Phase 4 4Phase 2/3 4

Status

Completed 16Unknown 8Recruiting 7Terminated 3Active not recruiting 3Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 4INDUSTRY 3

Study Type

Interventional 7

Sponsor

Cancer Type

CNS 7Lymphoid 1

Conditions

Breast Neoplasms 129Carcinoma, Non-Small-Cell Lung 101Prostatic Neoplasms 62Colorectal Neoplasms 49Nasopharyngeal Carcinoma 46Neoplasms 43Multiple Myeloma 41Stomach Neoplasms 34Lung Neoplasms 32Ovarian Neoplasms 31Neoplasm Metastasis 31Leukemia, Myeloid, Acute 31Carcinoma, Hepatocellular 29Squamous Cell Carcinoma of Head and Neck 27Rectal Neoplasms 27Triple Negative Breast Neoplasms 25Recurrence 25Pancreatic Neoplasms 25Small Cell Lung Carcinoma 21Esophageal Neoplasms 21Brain Neoplasms 21Uterine Cervical Neoplasms 20Colonic Neoplasms 20Lymphoma, Large B-Cell, Diffuse 18Head and Neck Neoplasms 17Urinary Bladder Neoplasms 16Leukemia, Lymphocytic, Chronic, B-Cell 16Esophageal Squamous Cell Carcinoma 16Carcinoma, Renal Cell 16Myasthenia Gravis 15

Interventions

Bevacizumab 3fluorodopa F 18 1contrast agent BR1 1Temozolomide 1TIC10 compound 1Radiation 1Microbubbles 1Methods 1Infusions, Intravenous 1Dexamethasone 1Adrenal Cortex Hormones 1Administration, Oral 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Glioma × Clear all
NCT05580562 2026-04-16

ACTION

Jazz Pharmaceuticals

Phase 3 Recruiting
510 enrolled
CNS

Glioma

NCT06496971 2026-04-09

A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

NaviFUS Corporation

Phase 3 Recruiting
32 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue

NCT05303519 2026-03-05

SIGMA

Nuvation Bio Inc.

Phase 3 Recruiting
365 enrolled
CNSLymphoid

Astrocytoma, Glioblastoma, Glioma, Lymphoma, Follicular, Oligodendroglioma

NCT06888817 2026-02-25

BRAINS

The Netherlands Cancer Institute

Phase 3 Recruiting
408 enrolled
CNS

Brain Neoplasms, Glioma, Radiation Injuries

NCT05271240 2024-09-19

Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

Northwell Health

Phase 3 Recruiting
432 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma

NCT05512403 2024-09-19

KING

Central Hospital, Nancy, France

Phase 3 Recruiting
88 enrolled
CNS

Glioma

NCT06330337 2024-03-26

Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade Glioma

The Third Affiliated hospital of Zhejiang Chinese Medical University

Phase 3 Recruiting
58 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡